Classification of autonomic drugs
Stimulate parasympathetic nervous system |
Cholinergic parasympathomimetic or muscarinic agonists |
Inhibit parasympathetic nervous system |
Anticholinergics parasympatholytic or muscarinic blockers |
Stimulate sympathetic nervous system |
Adrenergic sympathomimetics or adrenergic agonists |
Inhibit sympathetic nervous system |
Adrenergic antagonists anti-adrenergics or adrenergic blockers |
Classes of autonomic drugs
Cholinergics |
Stimulate the parasympathetic nervous system rest-and-digest Receptor: Acetylcholine (muscarinic) |
1. Direct acting 2.Indirect acting |
Anticholinergics |
Inhibit the parasympathetic nervous system, which induces fight-or-flight (sympathetic) |
Adrenergic |
Stimulate the sympathetic nervous system Result depends on type and location of receptor (ฮฑ or ฮฒ) |
๐1 agonist ๐2 agonist ๐1 agonist ๐2 agonist Catecholamines |
Adrenergic antagonist |
Inhibit sympathetic nervous system Action depends greatly on type of receptor (ฮฑ or ฮฒ) |
๐1 antagonist ๐1 antagonist ๐2 antagonist |
Primary neurotransmitters in the CNS
The CNS is responsible for our perception, mood, consciousness, behaviour, and cognition Therefore, drugs influence perception, mood, consciousness, behaviour, and cognition by altering neurotransmitter activity |
Serotonin (5HT) |
mood |
GABA |
inhibitory |
Norepinephrine (NE) |
stimulatory |
Dopamine (D) |
behaviour & movement |
Glutamate |
stimulatory |
Adverse effects of CNS drugs
Benzodiazepine |
drowsiness, sedation, memory loss, weakness, disorientation, ataxia, sleep disturbances, hypotension, blurred/double vision, nausea and vomiting |
Barbiturates |
Rarely prescribed anymore for anxiety or insomnia because of side effects |
Hypnotic/sedatives |
dizziness, headache, daytime drowsiness, dyspepsia, dry mouth, bitter metallic taste, nausea, anterograde amnesia |
Melatonin |
Adverse effects and monitoring mostly limited to drowsiness level (caution with endocrine dysfunction) because itโs identical to endogenous |
TCA's |
sedation, dizziness, orthostasis, blurred vision, dry mouth, tachycardia, cognitive impairment, constipation, dry eyes, urinary retention |
SSRI's |
Transient: headaches, nervousness, insomnia, nausea, diarrhea |
|
Long-term: Sexual dysfunction, withdrawal upon discontinuation |
MAOI's |
: constipation, dry mouth, headaches, changes in heart rate and blood pressure, insomnia, nausea, loss of appetite |
|
Food interactions |
foods containing tyramine = Hypertensive Crisis!!! |
Mood stabilizers |
Dizziness, fatigue, short-term memory loss, increased urination, GI upset, dry mouth, muscular weakness, tremors, excessive loss of sodium can lead to toxicity |
|
In the absence of sodium (Na), the cells take in lithium instead |
|
lithium toxicity |
Transient gastrointestinal symptoms are the earliest side effects to occur Mild degree of fine tremor of the hands may persist throughout therapy Thirst and polyuria may be followed by increased drowsiness, ataxia, tinnitus and blurred vision, indicating early toxicity As intoxication progresses the following manifestations may occur: confusion, increasing disorientation, muscle twitches, hyperreflexia, nystagmus, seizures, diarrhea, vomiting, and eventually coma and death |
CNS stimulants |
Insomnia, anxiety, restlessness, agitation, significant nausea/vomiting, anorexia (give with food), Cough, dry mouth, Tachycardia, hypertension, arrhythmias --> monitor and watch for signs of cardiovascular disease |
|
dose in AM or early afternoon |
Typical antipsychotics |
dizziness, drowsiness, orthostatic hypotension, dry mouth, dry eyes, constipation, blood dyscrasias (abnormal lab tests) |
|
EPS and NMS occur with typical antipsychotics |
Atypical antipsychotics (clozapine) |
significant agranulocytosis, seizures, tachycardia, NMS โข BUT HAS NO EPS |
Atypical antipsychotics (all the rest) |
drowsiness, dizziness, dry mouth, hyperglycemia, changes in cholesterol levels, weight gain, EPS |
Barbiturates for seizures |
Soft tissue irritant โ avoid injecting if possible IM โ inflammation; IV โ tissue necrosis Can cause vitamin deficiencies (D, B12, folate) โข Requires adequate supplementation |
Phenytoin |
dysrhythmias, headache, nystagmus, confusion, slurred speech, changes urine colour (red/brown), blood dyscrasias, hyperglycemia, gingival hypertrophy, skin reactions, osteoporosis |
Valproic Acid |
: sedation, GI upset, prolonged bleeding time, visual disturbances, ataxia, vertigo, muscle weakness, hepatotoxicity, pancreatitis, bone marrow suppression |
Succinimides |
mental and physical impairment, psychosis, behavioural changes, CNS effects, bone marrow suppression |
dopamine agonist |
reduced impulse control |
Opioid Analgesics |
sedation, fatigue, euphoria, confusion, constipation, respiratory depression, nausea, vomiting |
Opioid Antagonist |
minimal toxicity, however the effect of reversing analgesia will cause increased blood pressure, tremors, hyperventilation, nausea/vomiting and drowsiness (i.e. sudden withdrawal symptoms) |
NSAIDs |
gastric and epigastric discomfort, increased bleeding time, nausea, possible nephrotoxicity, cardiovascular events with long term use |
acetaminophen |
possible liver damage (hepatotoxic metabolite), causes less gastric irritation than aspirin, does not affect blood coagulation BUT can interact with warfarin |
Gabapentin |
Fatigue, weight gain, heartburn, ataxia, dizziness very common |
Pregabalin (Lyricaยฎ) |
Dizziness, fatigue, peripheral edema, dry mouth |
|
better tolerated than Gabapentin |
Corticosteroids |
infections, hyperglycemia, hypertension, thinning skin, easy bruising, moon face, osteoporosis, HPA-axis suppression |
Muscle relaxants |
sedation, dry mouth, urinary retention (anticholinergic effects) |
Anesthetics |
tingling, mucosal irritation, CNS toxicity, cardiovascular collapse |
Duloxetine (Cymbaltaยฎ) |
Nausea, dizziness, fatigue all common |
Triptans |
dizziness, drowsiness, warming & prickling sensation, may experience rebound headache Vasoconstriction =โ BP |
Ergot Alkaloids |
leg weakness, muscle pain in extremities, nausea and vomiting |
Serotonin Syndrome
โ risk when >1 drug that increases serotonin in the body
Not always obvious due to promiscuity โ triptans, tramadol, etc.
symptoms: Hypertension, tremors, sweating, shivering, confusion, anxiety, restlessness, tachycardia, muscle twitching
Anywhere from 30 mins after dose --> weeks after dose of the 2nd drug
Emotional & Mood Disorders
Depression
Mood Disorders (Bipolar)
Post-traumatic Stress Disorder (PTSD)
Attention Deficit Hyperactivity Disorder (ADHD)
Many more (hundreds)
Medication for Emotional & Mood Disorders
Antidepressants |
1.Tricyclic antidepressants (TCAs) |
Work by inhibiting reuptake of norepinephrine, serotonin, and dopamine, leaves more neurotransmitter within cleft |
|
-triptyline; -pramine -oxepine |
|
2.Selective serotonin inhibiters (SSRIs) |
Work by inhibiting reuptake of serotonin only |
|
Citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline |
|
3. Monoamine oxidase inhibitors (MAOIs) |
Reserved for people who havenโt responded to SSRI or TCA Inhibits monoamine oxidase (MAO) which breaks down norepinephrine leaves more norepinephrine in the synaptic cleft breaks down dopamine, epinephrine, and serotonin leaves more of these neurotransmitters as well causing many side effects and interactions |
|
Phenelzine, tranylcypromine, moclobemide |
|
4. Atypical antidepressants |
Inhibiting reuptake of serotonin, norepinephrine and dopamine activity with different affinities Also work on other receptors like histamine |
|
Bupropion (Wellbutrinยฎ, Zybanยฎ)(NDRI), mirtazapine (Remeronยฎ)(SNRI), venlafaxine (Effexorยฎ)(SNRI), duloxetine (Cymblataยฎ)(SNRI), trazodone (Desrylยฎ)(SARI) |
Mood stabilizers |
Work by altering sodium transport across cell membranes By altering sodium transport, it influences the release, synthesis, and reuptake of multiple neurotransmitters |
|
Primarily used for bipolar disorder (manic-depression) |
|
Lithium carbonate |
|
Anticonvulsants: carbamazepine, divalproex, lamotrigine, valproic acid, gabapentin, topiramate |
Anticonvulsants are also used as mood stabilizers because they also alter transport of ions across cell membranes |
CNS stimulants |
Work by heightening awareness and increasing focus (non-specifically) Primarily used for ADHD in children and adults All cause an increase in attentiveness and heightened awareness by influencing NE and D release somehow |
|
Methylphenidate (Ritalinยฎ, Concertaยฎ, Biphentinยฎ) Dextroamphetamine (Dexedrineยฎ) Dextroamphetamine and amphetamine (Adderallยฎ) Lisdexamfetamine (Vyvanseยฎ) |
Degenerative diseases
Parkinson's disease |
Gradual destruction of neurons from substantia nigra โ striatum of brain that use dopamine to communicate Movements and impulses essential to performance of movements โ number of dopaminergic neurons โ โ dopamine Symptoms are a characterization of โ dopamine |
Parkinson's symptoms |
Classic features: Tremor, Bradykinesia, Rigidity, Loss of balance Other features; Depression, anxiety, mood change, Memory loss --> dementia, Difficulty concentrating, Change in sense of smell, Change in sleeping patterns, Constipation, light-headedness, sweaty, Difficulty swallowing, chewing, speaking, blinking |
Dementia |
A term that describes a decline in a variety of functions (e.g. memory, language, motor activities, ability to recognize or identify objects, complex decision-making) which eventually causes a person to have difficulty performing everyday activities |
Types of Dementia |
Alzheimerโs Disease |
amyloid plaques and tangles |
Vascular Dementia |
reduced blood supply |
Frontotemporal Dementia |
younger patients, highly genetic, odd behaviours |
Lewy Body Dementia |
presence of Lewy Bodies, well-formed hallucinations |
Parkinsonโs Disease Dementia |
Parkinsonโs usually diagnosed first โ both neurodegenerative |
Parkinson's disease management: All pharmacotherapy focuses on โ dopamine levels (directly or indirectly)
Classes of medication for Parkinson's
Levodopa |
Effective cornerstone of therapy Dopamine cannot cross blood-brain barrier (BBB) The enzyme that creates dopamine (decarboxylase) is everywhere in the body Levodopa โ crosses BBB โ converted to dopamine via decarboxylase It is a prodrug Levodopa is always paired with either carbidopa or benserazide (decarboxylase inhibitors that DO NOT cross BBB), which does two things: 1) Enhances distribution to brain 2) Minimizes acute side effects Because conversion to dopamine occurring past BBB (mostly) |
Dopamine Agonists |
stimulate dopamine receptors |
MAO-B Inhibitors (MAOIs) |
inhibit the enzyme that breaks down dopamine |
Amantadine |
either releases more dopamine or inhibits re-uptake of dopamine (exact mechanism unknown) also anti-viral |
COMT Inhibitors |
inhibit peripheral conversion of levodopa to dopamine (making levodopa more efficient) |
Anticholinergics |
block acetylcholine, which restores balance of acetylcholine and dopamine for tremor only |
All other medications for Parkinson's (excluding Levodopa) work to either directly or indirectly toโ dopamine in brain
Classes of medication for Dementia
Treatment of Dementia |
1.Cholinesterase Inhibitors Donepezil, galantamine, rivastigmine |
Prevent breakdown of acetylcholine (Theory: lack of acetylcholine causes plaques & tangles) May show small improvements in measures of cognition and activities of daily living (ADL) (1-3 points on MMSE) May slow progression (by months, not years) If benefit, seen in 3-6 months Only approved for Alzheimerโs but prescribed for all types |
2.N-methyl-D-aspartate (NMDA) antagonist Memantine |
Block glutamate (excitatory amino acid) at NMDA receptor (Theory: persistent activation of NMDA contributes to symptoms) No effect on acetylcholine Alone or in combo with cholinesterase inhibitor โ directly conflicting evidence re: benefit Indication: Moderate โ Severe Alzheimerโs Renally excreted (dosage adjustment needed for impairment) |
Management of Behavioural & Psychological Symptoms of Dementia (BPSD) |
Antipsychotics, benzodiazepines, antidepressants, stimulants and more |
Classification of Pain
Duration |
A.Acute pain |
Intense, Less than 6 months E.g. sprained ankle |
B. Chronic pain |
Persists for longer than 6 months, Interferes with daily activities, Associated with feelings of hopelessness E.g. permanent nerve injury |
Source |
A. Nociceptor |
Pain Due to injury to tissues Sharp, localized; or Dull, throbbing, aching E.g. paper cut, broken bones |
B. Neuropathic Pain |
Due to injury to nerves Burning, shooting, numbing E.g. nerve injury, shingles |
Pharmacological management
Requires thorough:
Health history (including allergies)
BPMH โ best possible medication history
Includes an assessment of stress, coping mechanisms, potential for dependency
Baseline assessment including character, location, duration and intensity of pain
Migraines
Goal of treatment |
To reduce acute pain via 1.Triptans or 2.Ergot alkaloids |
|
To prevent further migraines from occurring If patient experiences a significant amount of migraines ฮฒ-blockers, anticonvulsants (topiramate, valproic acid), calcium channel blockers, TCAs, venlafaxine |
Classes of drugs for migraines |
1.Triptans |
Selective serotonin receptor agonist on intracranial blood vessels and sensory nerves on the trigeminal system Causes vasoconstriction and reduces neurogenic inflammation, relieving migraine headache Used for acute cluster headaches or migraines (with or without aura) as early as possible Available as regular oral tabs, oral disintegrating tablets, injections, nasal spray (due to frequent nausea/vomiting) โ we want quick onset Expensive (require EDS in Sask) Interaction with any other drug that also โ serotonin ๏ serotonin syndrome Tolerance can develop โ remind patients to use only when necessary and as few doses as needed |
2.Ergot alkaloids |
Serotonin receptor agonist and interacts with dopamine and adrenergic receptors (ฮฑ-blocker) Therefore, more adverse effects Dihydroergotamine โ given IV, may see repeated administration for 3-7 days to break cycle of repeat migraines DO NOT GIVE WITHIN 24 HOURS OF TRIPTAN Additive vasoconstriction --> coronary vasospasm Mostly used if triptans fail |
Migraine Monitoring:
History of migraines, triggers, and previous treatment, focus on prevention
Effectiveness of treatment (assess pain level)
Blood pressure and pulse
Watch for chest pain, palpitations, confusion, tingling in extremities, or sudden change of headache status (Fever? Rash? Stiff neck?)
Headaches are usually a symptom
|
|
Nervous system
Branches of peripheral nervous system |
1.Somatic nervous system |
Voluntary control over skeletal muscles |
|
2. Autonomic nervous system |
Involuntary control over smooth and cardiac muscle and glands Divided into sympathetic and parasympathetic |
Autonomic nervous system |
1. Sympathetic |
Activated under stress Fight-or-flight response Primitive response to avoid harm |
|
2. Parasympathetic |
Activated under non-stressful conditions Rest-and-digest response |
Primary neurotransmitters in the periphery
Norepinephrine (NE) |
Binds with adrenergic receptors |
|
Alpha (ฮฑ) receptors (ฮฑ1 & ฮฑ2) |
ฮฑ1-adrenergic Receptors In sympathetic target organs except heart ฮฑ2-adrenergic Receptors At presynaptic adrenergic neuron terminals |
|
Beta (ฮฒ) receptors (ฮฒ1 & ฮฒ2) |
ฮฒ1-adrenergic Receptors Mostly in heart muscle ฮฒ2-adrenergic Receptors Mostly in the lungs |
Acetylcholine (Ach) |
Binds with cholinergic receptors |
|
Muscarinic receptors |
Binding to muscarinic receptor varies between stimulatory and inhibitory action, depending on site |
|
Nicotinic receptors |
Skeletal muscle, smooth muscle, glands Not many useful drugs affect nicotinic receptors |
Adverse effects of autonomic drugs
Cholinergics |
salivation, sweating, abdominal cramping and hypotension |
Anticholinergics |
dry mouth, constipation, urinary retention, confusion, tachycardia Less mucous production = dry mouth, eyes, nose Pupil dilation, blurred/double vision, increased intraocular pressure Less sweating = โ in body temp Urinary retention = โ risk of infection CNS = Agitation, inability to concentrate, confusion -> delirium, hallucinations, illogical thinking, incoherent speech |
ฮฑ-adrenergics |
Oral - anxiety, restlessness, tremor, hypertension, tachycardia Nasal โ burning of mucosa, rebound congestion if used for long periods |
adrenergic antagonist ฮฒ1 -blocking |
bradycardia, hypotension, headache, fatigue, dizziness, sleep disturbances, nausea; most are dose-related and appear early in therapy Rebound tachycardia, arrhythmias and infarction if discontinued suddenly |
Anxiety and Sleep Disorders
Anxiety Disorders |
Generalized anxiety disorder (GAD) ,Phobias, Panic disorders, Obsessive-compulsive disorder (OCD), Post-traumatic stress disorder (PTSD) |
Sleep Disorders |
Either an inability to: Fall asleep, Stay asleep, or Both |
In both anxiety and sleep disorders, nonpharmacological management is more effective LONG TERM
Medications provide relief but should be used for SHORT TERM if possible in addition to non-pharmacological management
CNS depressants
|
1.Benzodiazepines |
Intensify GABA (bind to benzodiazepine receptors on a GABA receptor) |
2.Barbiturates |
Enhance GABA (bind to barbiturate receptor on GABA receptor) |
3.Hypnotics/Sedatives |
Commonly also use a benzodiazepine receptor to potentiate GABA, but much more specific |
|
Bind only to GABA1 for sleep Only cause sedation no anxiolytic or anticonvulsant properties |
4.Miscellaneous |
Can act on any neurotransmitter any drug that causes sedation can potentially be used to induce or prolong sleep even if it is an adverse effect |
|
Includes antihistamines such as diphenhydramine (Benadrylยฎ), dimenhydrinate (Gravolยฎ) or hydroxyzine (Ataraxยฎ) |
CNS depression is a continuum |
muscle relaxation>sedation>induce sleep>anesthesia>coma>death |
Slow down neural activity in the brain, May or may not be specific for certain neurotransmitters
Classes of Medication for Psychosis
Typical antipsychotics |
conventional, 1st generation - good at managing positive symptoms, no dependence D > 5HT More side effects (especially EPS) than atypical |
A. Phenothiazines Chlorpromazine |
Blocks post-synaptic dopamine receptors; also blocks histamine and muscarinic receptors Used to manage mania and psychosis, prevention and treatment of nausea and vomiting |
other phenothiazines:Fluphenazine, Methotrimeprazine, Perphenazine, Promazine, Trifluoperazine |
B. Non-Phenothiazines Haloperidol |
Blocks post-synaptic dopamine receptors Used to manage psychotic disorders, Touretteโs, manic states; also an antiemetic |
other non-phenothiazines: Flupentixol, Loxapine, Pimozide, Thiothixene, Zuclopenthixol |
Atypical anti-psychotics |
unconventional, 2nd generation Newer class โ now drugs of choice No dependence More specific for serotonin than dopamine receptors, with different affinities Also bind to ฮฑ-receptors in periphery Less side effects (especially EPS) than typicals/1st Gen |
A.Clozapine |
Blocks dopamine receptors; also blocks serotonin, muscarinic, and histamine receptors Reserved only for treatment-resistant schizophrenia because of adverse effects does not have EPS |
B. Quetiapine (Seroquelยฎ) |
Blocks serotonin receptors; also slightly blocks dopamine receptors Used to treat schizophrenia and bipolar disorder; also used in the behavioural and psychological symptoms of dementia (BPSD) |
Others atypicals:Olanzapine (Zyprexaยฎ) Risperidone (Risperdalยฎ) Paliperidone (Invegaยฎ) Ziprasidone (Zeldoxยฎ) |
Miscellaneous |
A.Aripiprazole (Abilifyยฎ) |
Partial dopamine and serotonin agonist; also serotonin antagonist at other sites Used for schizophrenia, bipolar, and depression (as an add-on) Fewer side effects but not as effective as others Will also see combinations of antidepressants, mood stabilizers, and benzodiazepines |
Antipsychotics are not a cure for schizophrenia โ but they are effective if continued
Medications are only effective for as long as the client takes the medication โ no dependence
They often have multiple undesirable side effects:
Agranulocytosis, EPS, weight gain, sedation, dyskinesias, anticholinergic effects
Effectiveness can lead to discontinuation
Seizure disorders
Seizure |
a disturbance of electrical activity in the brain that can affect consciousness, motor activity, and sensation Not every seizure consists of convulsions Many types starting with local (one section) or generalized (whole brain) |
Convulsions |
involuntary, violent spasms of the large skeletal muscles of face, neck, arms, and legs |
Epilepsy |
a disorder characterized by recurrent seizures Those seizures can be any type You can experience a seizure without having epilepsy |
Causes of seizures |
Infectious diseases Trauma to head Metabolic disorders like dehydration, hypoglycemia, kidney disease, electrolyte imbalances Vascular diseases causing lack of oxygen Pediatric disorders febrile seizures Tumours |
Seizure Threshold |
the balance between excitatory and inhibitory forces in the brain which affect how susceptible a person is toย seizures Important: many drugs that alter CNS activity can lower the seizure threshold โ this leads to many potential drug interactions |
Classes of Medication for seizure disorders
Drugs that potentiate GABA |
a.Barbiturates |
Potentiate GABA (inhibitory) and suppress the firing ability of neurons by stimulating an influx of Cl- CNS depressants Takes several weeks for control May be used as monotherapy |
Phenobarbital |
Causes least sedation Follows CNS depression spectrum Dependence and withdrawal occur |
b.Benzodiazepines |
Intensify GABA by binding to benzodiazepine receptors, which stimulates an influx of Cl- Work very quickly if injected (used in status epilepticus) Usually an adjunct to other drugs because of dependence and tolerance โ reason to use short-term only Follow CNS depression spectrum |
Diazepam |
As an anti-convulsant, used for short-term seizure control, calming and relaxation |
c.Miscellaneous |
Primidone โ some classify as a barbiturate Topiramate โ a combo of mechanisms (blocks Na+ influx, enhances GABA at some receptors - different from benzodiazepines, and more) |
Drugs that suppress Na+ influx |
|
Desensitize Na+ channels, which prevents influx of Na+ (different from blocking or antagonizing) Sodium movement is a main factor that determines whether neuron will undergo an action potential (excitation) No dependence or tolerance Not all require lab monitoring In CNS action potentials Na+ > Ca+ |
a.Hydantoins (phenytoin and fosphenytoin) |
Very common, treats many types of seizures Very narrow therapeutic range โ requires monitoring LOTS of drug interactions with anticoagulants, corticosteroids, supplements; impairs oral contraceptives and some antibiotics |
b.Miscellaneous (phenytoin-like) carbamazepine, lamotrigine, valproic acid (& divalproex)
|
Still desensitizes sodium channels, which prevents influx of Na+ Used for absence and mixed-type seizures |
Drugs that suppress Ca+ influx |
a.Succinimides Ethosuximide and methsuximide |
Block calcium channels, which delays Ca+ influx, which depresses the activity of neurons in the motor cortex Calcium influx is not as dominant as sodium influx In CNS action potentials Na+ > Ca+ |
b. Gabapentin |
โ unknown mechanism for anticonvulsant activity Is shaped like GABA (hence the name), but does NOT bind to GABA receptors Binds to calcium channels to reduce calcium influx Used mostly for neuropathic pain and migraines now |
We use drugs that can:
a.Stimulate an influx of Cl- ions, which potentiates GABA
b.Delay an influx of Na+
c.Delay an influx of Ca+
In CNS action potentials Na+ > Ca+
Drug Classes for Pain
Analgesics |
a.Opioid analgesics |
Work in spinal cord and brain (CNS) to alter perception of pain Moderate to severe pain Some used for anesthesia Different levels of potency/efficacy โ all are compared to morphine (Gold Standard) |
Routes for administration |
Oral: Systemic effects all over the body at opioid receptors Parenteral: Localized or systemic โ depends how we do it |
Morphine |
Routes: PO, IV, IM, SC, rectal, epidural, intrathecal Remember โ 5mg PO ว 5mg IV Duration of action: PO โ 4 to 7h IV โ 4 to 5h Epidural โ 4 to 24h |
Opioid dependency |
Physical dependence lasts 7 days Psychological dependence can last many months or years Often, patients switch from IV and inhalation forms to oral form called methadone |
Methadone |
A long lasting opioid that avoids withdrawal symptoms by stimulating receptors, with no euphoria Has a long tยฝ - most only need to dose once daily (still patient variation) |
opioid antagonist Naloxone and naltrexone |
Competitively binds to and blocks mu and kappa receptors Blocking opioid receptors would only biologically change something in someone taking an opioid Used to reverse opioid effects Can be a diagnostic tool |
naloxone |
Opioid antagonist used to reverse opioid toxicity (i.e. respiratory depression is the lethal symptom) Higher affinity for opioid receptors, therefore displaces opioid (competitive antagonist) No euphoria, no dependence or tolerance Schedule II (for emergency purposes only) Effects = instant withdrawal symptoms: Pain, hypertension, sweating, anxiety, irritability + (very uncomfortable to patient, but not life-threatening) Not a substitute for ambulatory care, but can keep someone alive longer If opioid agonist is longer acting than naloxone (i.e. methadone), toxicity could return |
b.Non opioid analgesics |
Work in peripheral tissues to prevent formation of pain impulses Most non-opioids are also effective for fever, inflammation, and analgesia Used for mild or moderate pain associated with inflammation Acetaminophen vs. NSAIDs Acetaminophen does not have anti-inflammatory properties Both have anti-pyretic and analgesic effects |
Non-steroidal anti-inflammatory drugs NSAIDs Aspirin (ASA), ibuprofen, naproxen (OTC) |
Primary drugs for the treatment of mild to moderate inflammation Inhibit cyclo-oxygenase (COX), a key enzyme in the biosynthesis of prostaglandins Prostaglandins promote inflammation Reducing prostaglandins effectively reduces inflammation NSAIDs can be selective for COX-2 or non-selective ALSO anticoagulant, antipyretic, anti-inflammatory Primary use: for fever, arthritis, mild to moderate musculoskeletal pain, dysmenorrhea Some drug interactions Caution in elderly due to poor kidney function No ASA in children โ Reyeโs Syndrome |
Acetaminophen |
Reduce fever at level of hypothalamus and dilation of peripheral blood vessels Enables sweating and dissipation of heat Primary use is to relieve mild-moderate pain and reduce fever No anti-inflammatory actions |
Miscellaneous |
Focus is the CNS used for neuropathic pain
|
a.Gabapentin |
while shaped similarly to GABA, does not bind to GABA receptors; binds to calcium channels and reduces calcium influx |
b.Pregabalin (Lyricaยฎ) |
reduces calcium influx at nerve terminals, which may reduce transmission of nerve pain |
Corticosteroids |
Cortisol is released by adrenal glands in response to stimuli to help restore body to normal Drugs synthetically made to mimic cortisol They are anti-inflammatory and immuno-suppressive Primary use: for severe inflammation or immuno-suppression |
Muscle relaxants Methocarbamol, cyclobenzaprine, baclofen, hyoscine |
After sustaining an injury, muscle spasms may occur to stabilize the affected body part and prevent further damage - also generate pain Most work in brain to reduce tonic, somatic motor activity in alpha and gamma systems NOT on muscle cells NOT at neuromuscular junction |
Anesthetics |
A drug that causes anesthesia, reversible loss of sensation Stabilize the neuronal membrane, preventing initiation and conduction of impulses Primary use is surgery, epidurals General: a reversible loss of consciousness Local: a reversible loss of sensation for a limited region of the body while maintaining consciousness |
Anti-depressants |
TCAs |
Primary use is depression, moving towards chronic pain Migraines, nerve pain, fibromyalgia, etc. Neuropathic pain (due to effect on neurotransmitters) |
SSRI's Citalopram, fluoxetine, sertraline, paroxetine |
Selective for serotonin, less side effects than TCAs Also treat concurrent depression and anxiety disorders May be effective for chronic fatigue, hot flashes, mostly used off-label for other pathologically similar conditions |
Duloxetine (Cymbaltaยฎ) |
serotonin and norepinephrine reuptake inhibitor Now indicated for pain associated with diabetic peripheral neuropathy, fibromyalgia, chronic low back pain, and osteoarthritis of the knee Also depression and generalized anxiety disorder |
Anti-anxiety meds |
Benzodiazepines Not a direct MOA, more of a co-morbidity of anxiety along with pain Worry about tolerance and dependence with long term use Encourage PRN (as needed) use, other coping mechanisms, counselling |
Pain management is subjective and difficult to manage due to consistent change of condition, tolerance, and dependence โ and racism
Patient is guide to treatment
Difficult to know when to encourage more or less use of analgesics
|
Created By
Metadata
Favourited By
Comments
No comments yet. Add yours below!
Add a Comment
Related Cheat Sheets
More Cheat Sheets by kjaniskevich